Roche Hit By Surprising Tecentriq Miss In TNBC

Has Improved Survival With Nab-Paclitaxel But Not With Paclitaxel

 
• By Kevin Grogan
  
Roche tower
Roche HQ: Will Swiss major rue IMpassion131 study miss? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D